![Manish Tandon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manish Tandon is currently Senior Vice President-Business Development at Ascentage Pharma Group International Co., Ltd. Formerly, Dr. Tandon was Senior Director-Business Development at ArQule, Inc. and Vice President-Business Development at InnoCare Pharma Ltd. Dr. Tandon completed a doctorate at Brown University, an undergraduate degree at the University of Delhi, and an MBA at Questrom School of Business.
| Companies | Position | Start |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| INNOCARE PHARMA LIMITED | Corporate Officer/Principal | - |
| ARQULE, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Questrom School of Business
 Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InnoCare Pharma Ltd.
 InnoCare Pharma Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of cancer and autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
